Multisystemic Inflammatory Syndrome Temporally Associated with COVID-19 in a Regional Pediatric Hospital from México

Author:

Barroso-Santos Joel1,Robledo-Martínez Angelina Ingrid1ORCID,Espinosa-Padilla Sara Elva2,Hurtado del Ángel Rubén Genaro1,Arteaga-García Felipe1ORCID,Langarica-Bulos Mónica1,Madrid-Gómez-Tagle José Antonio3,Sánchez-Reyes Beatriz Adriana1,Hernández-Cadena Sarai Eunice3,Suárez-Soto Jorge Iván1,Delgado-Amézquita Carolina1,Godínez-Hernández Brenda1,Otamendi-Canales Octavio1,Jiménez-Osorio Angélica Saraí45ORCID

Affiliation:

1. Hospitalization Service, Hospital del Niño DIF Hidalgo, Pachuca 42080, Hidalgo, Mexico

2. Immunodeficiency Research Unit, National Institute of Pediatrics, Coyoacán, Mexico City 04530, Mexico

3. Immunology and Allergy Service, Club Pediatría, Pachuca 42080, Hidalgo, Mexico

4. Área Académica de Enfermería, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, San Agustín Tlaxiaca 42060, Hidalgo, Mexico

5. Research Service, Hospital del Niño DIF Hidalgo, Pachuca 42080, Hidalgo, Mexico

Abstract

Multisystemic inflammatory syndrome (MIS-C) is an inflammatory condition temporally associated with COVID-19 in children; nevertheless, the clinical and immunologic spectrum of MIS-C is heterogeneous, and its long-term effects are unknown. During the period of August 2020 to December 2021, a total of 52 MIS-C cases were confirmed in pediatric patients from the Hospital del Niño DIF Hidalgo, diagnosed using criteria from the World Health Organization. All patients had serologic IgG confirmation of SARS-CoV2, the mean age of the patients was 7 years, and 94% of the patients did not have a previous underlying disease. In addition to the presentation of lymphopenia, neutropenia, and thrombocytopenia, elevations in D-dimer and ferritin levels were observed in all patients. There was clinical improvement with intravenous gamma globulin and corticosteroid treatment.

Publisher

MDPI AG

Subject

Pediatrics

Reference33 articles.

1. Royal College of Paediatrics and Child Health (2022, March 03). Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19 (PIMS)—Guidance for Clinicians [Internet]. Available online: https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance.

2. Multisystem Inflammatory Syndrome in children;Soma;Infect. Dis. Immun.,2020

3. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3;Henderson;Arthritis Rheumatol.,2022

4. Detection of Antigen in Bronchial Epithelium and Macrophages in Acute Kawasaki Disease by Use of Synthetic Antibody;Rowley;J. Infect. Dis.,2004

5. PIMS-TS and Kawasaki Disease: The Mystery Deepens;Lutchman;Pediatr. Infect. Dis.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3